Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2020 08:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences to Present During the Jefferies Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 26, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis...
May 19, 2020 16:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces Move to Virtual-Only Annual Meeting of Stockholders on June 11, 2020

SOUTH SAN FRANCISCO, Calif., May 19, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB) today announced that it will hold its 2020 Annual Meeting of Stockholders (Annual Meeting)...
May 07, 2020 16:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Reports Updates on Corporate Progress and First Quarter 2020 Financial Results

-- Advancing the development of three clinical-stage core inhibitor candidates in HBV portfolio ---- Cash position of $249 million projected to fund operations into 2022 ---- Company to host HBV...
May 04, 2020 08:00 ET | Source: Assembly Biosciences, Inc.

Preclinical Data from Assembly Biosciences’ Microbiome Program in Ulcerative Colitis Featured in DDW 2020 Virtual Meeting Portal and Upcoming Journal Supplements

SOUTH SAN FRANCISCO, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis...
May 01, 2020 17:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., May 01, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis...
April 30, 2020 16:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences to Host Conference Call and Webcast to Review HBV Portfolio Progress

SOUTH SAN FRANCISCO, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting...
April 06, 2020 08:00 ET | Source: Assembly Biosciences, Inc.

Research by Assembly Biosciences and Academic Collaborators Published in Hepatology Indicates cccDNA Turnover Time May Enable Hepatitis B Cures Following Finite Therapy

SOUTH SAN FRANCISCO, April 06, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B...
March 31, 2020 16:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., March 31, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting...
March 30, 2020 08:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Appoints Jason Okazaki as Chief Legal and Business Officer

SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting...
March 04, 2020 16:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Reports Fourth Quarter and Year End 2019 Financial Results

SOUTH SAN FRANCISCO, Calif., March 04, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting...